GlaxoSmithKline PLC (GSK) stock prices updated...
 

GlaxoSmithKline PLC stock price, GSK

GlaxoSmithKline PLC stock chart:



GlaxoSmithKline PLC close price: 43.26

Stock price forecast:

DOWN TO -1.09%
Target: 42.79

Total forecasts: 82
Reached: 15 (18.29%)

Total Win: 12.30 (29.40%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90831518.07%12.300.35%2,845.07-96.61-3.40%-84.31-2.43%
303113.23%0.700.05%1,261.72-36.08-2.86%-35.38-2.71%
141500.00%0.000.00%644.38-4.52-0.70%-4.52-0.70%
7800.00%0.000.00%346.080.000.00%0.000.00%

Showing 1-10 of 558 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-05-2343.2642.780000-00-00
2017-05-2243.2642.90000-00-00
2017-05-2143.2642.90000-00-00
2017-05-2043.2642.860000-00-00
2017-05-1943.2642.860000-00-00
2017-05-1843.2642.80000-00-00
2017-05-1743.2642.710000-00-00
2017-05-1643.2642.640000-00-00
2017-05-1543.2642.540000-00-00
2017-05-1443.2642.520000-00-00

GlaxoSmithKline PLC latest news:


  • 05/10/2017 10:35:09

    Mylan disagrees with FDA over generic Advair rejection

    (Reuters) - Generic drug maker Mylan NV said on Wednesday it disagrees with the U.S. Food and Drug Administration, which declined to approve Mylan's generic for GlaxoSmithKline Plc's blockbuster Advair in March.

  • 03/31/2017 16:59:07

    Mylan Receives CRL for Generic Advair Diskus From the FDA

    Mylan N V MYL recently suffered a huge setback The company received a complete response letter from the FDA regarding its abbreviated new drug application ANDA for the generic version of GlaxoSmithKline s GSK asthma drug Advair Diskus The company is in the process of reviewing

  • More trends:

    Global Brass and Copper HoldingsBRSS | Global Cash Access HoldingsGCA | Global High Income Dollar FundGHI | Global Net LeaseGNL | Global Partners LPGLP | Global Payments Inc.GPN | Global Power Equipment Group IncGLPW | Global Ship LeaseGSL | Global Ship LeaseGSL^B | Globant S.A.GLOB |